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Background: The epidemiology of Burkitt Lymphoma (BL) shows that the endemic type is mainly confined to
equatorial Africa and has a very close association with the Epstein-Barr virus (EBV), while the sporadic variant shows
only a 20% association with EBV and is seen mainly in Europe and North America. An immunodeficent form of BL
has been described more recently. This study aimed to describe the epidemiological characteristics and survival of
children presenting with BL to Tygerberg Hospital, Cape Town, in South Africa.
Methods: A retrospective, descriptive study reviewed all pediatric cases of Burkitt lymphoma at Tygerberg Hospital
Oncology Unit between 1 January 1995 and 31 December 2010. The following data were analysed: age at
diagnosis, gender, anatomic site, race, socio-economic demographic (rural vs. urban), treatment protocol, side
effects, viral characteristics and survival. All cases were confirmed by histology and reviewed by a tumour board.
Results: A total of 51 patients with Burkitt lymphoma were analysed from 1995 to 2010. Their age ranged from 2
to 14 years (mean of 6.8 years).The male to female ratio was 3.6/1. Most of the patients lived in an urban setting
(52.9%). The initial presenting tumour site was abdominal in most cases (76.4%). The majority of patients (90%) were
treated with the LMB protocol. Neutropenic sepsis, mucositis and gastroenteritis were the top 3 side effects while
receiving therapy (58.8%, 50.9% and 31.3% respectively). The overall survival rate was 64.7%. A documented positive
HIV1 test was found in 11% of the total number of patients. The stage of the disease at the time of presentation
strongly influenced the outcome with only 41.6% of stage 4 patients surviving (p = 0.03).
Conclusions: The patients seen at Tygerberg Hospital, South Africa presented typically with the sporadic variant of
Burkitt Lymphoma. The patients presented with large abdominal masses and in an advanced stage of the disease.
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Burkitt Lymphoma (BL) is common amongst children,
especially in Africa. BL accounts for 30 to 50% of all
childhood cancer in equatorial Africa with an estimated
incidence of 3 to 6 cases per 100,000 children per year
[1]. The incidence of BL in Africa is approximately 50-
fold higher than that seen in the United States (US) [2].
It was first described in Eastern Africa as a sarcoma of
the jaw [3].
The three clinical variants of BL are classified as en-
demic, sporadic and immunodeficient, according to their
epidemiological characteristics.* Correspondence: cs@sun.ac.za
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article, unless otherwise stated.The peculiar epidemiology of BL showed that the endemic
type was mainly confined to equatorial Africa and has a very
close association with the Epstein–Barr virus (EBV), with
approximately 95% of the ‘endemic’ cases showing the pres-
ence of the EBV genome in their tumour cells. The endemic
form typically presents in younger children with jaw masses
and often spreads to the central nervous system.
BL is not restricted to Eastern Africa, it occurs else-
where too, but with a lesser incidence. This was classified
as the sporadic form of the tumour. The tumours found
outside the Central African Belt (according to the WHO,
the BL belt extends from East to West between 10 degrees
north and 10 degrees south of the equator, continuing
along the eastern coast of Africa) showed also different
viral characteristics – EBV being present only in 20% of
cases [4].Central Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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(HIV-1) to be significantly associated with BL [5]. Such
cases are classified as immunodeficiency BL and can also
be associated with organ transplantation, secondary to im-
munosuppressive drugs. BL can, in fact, be one of the dis-
eases associated with the initial manifestation of AIDS [6].
Almost half of the patients (40 – 50%) of HIV–associated
BL are positive for EBV [6].
In South Africa, the immunodeficient form of BL is seen
with increasing frequency. The literature is controversial
with regard to the predominance of the other two forms,
endemic and sporadic BL, in children: older studies pub-
lished found that patients closely resembled endemic BL
while more recent literature indicates that children present
the sporadic variant [6-8].
This study aimed to describe the demographic charac-
teristics of the patients diagnosed and treated for BL in
the pediatric oncology unit at Tygerberg Hospital, Cape
Town, South Africa and to examine the similarities and
differences between sporadic Burkitt lymphoma and en-
demic Burkitt lymphoma. In addition to the epidemio-
logical features, the treatment protocol used, the adverse
effects, relapse, association with HIV infection and corre-
lation of the stage with ethnic groups and survival were
analysed.
Methodology
The study population included all paediatric patients
(<15 years) diagnosed with BL (confirmed by histology or
cytology by a pathologist) and managed in the pediatric
oncology unit, from 1 January 1995 to 31 December 2010.
Data extracted from the records included the patient’s
birth date, age at diagnosis, sex, ethnicity, anatomical site
of the primary tumour, tumour stage, systems involved by
tumour and site of metastases and HIV-1 serology results.
Data were taken out from the local tumour registry of
the unit and the findings were correlated with the national
childhood cancer registry. All cases were confirmed by bi-
opsy and histopathology.The following markers were used:
CD45, CD3, CD20, bcl-6, CD10, TdT & ki-67. Molecular
tools were not used as they became available only in the
last few years.
The treatment protocol used was based on the French
Paediatric Oncology Society protocol LMB – 89 [9]. All pa-
tients were treated for prevention or diagnosis of tumour
lysis syndrome with allopurinol, hyperhydration and urin-
ary alkalisation at the start of the induction.
Staging investigations done to assess the extent of dis-
ease, included imaging studies (chest radiography, abdom-
inal ultrasound), lumbar puncture with CSF evaluation as
well as bilateral bone marrow aspirate and trephine.
Some of the children had computerized tomography
scans. The stage was determined according to the St
Jude Staging system.Adverse effects of the treatment were recorded.
The 5 year overall survival was calculated from the diag-
nosis date. All patients were followed up at the same clinic.
From 2001 onwards all children were tested for HIV
infection as a routine examination. Data were missing
regarding results prior to this date.
The extracted data was recorded in Excel format. De-
scriptive statistics including frequency tables, histograms,
means and standard deviations were performed. Data were
compared using the chi square test, ANOVA or cross tab-
ulations depending on the type of data.
Ethical approval
Ethical approval for this study was obtained from the
Health Research Ethics Committee of the University of
Stellenbosch; ethics reference number N11/03/100. The
manager of Tygerberg Hospital approved the retrieval of
data from the Tygerberg Hospital folders.
Results
A total of 51 patients with histologically confirmed Burkitt
Lymphoma were reviewed from 1 January 1995 to 31
December 2010.
Age and ethnicity
The age group of the patients ranged from 2 to 14 years
with a median age of 6 years and a mean of 6.8 years (SD =
3.82). Coloured or mixed ancestry patients were the major-
ity of the patients, 62.7% (n = 32), white patients repre-
sented 19.6% (n = 10), and black patients, 17.6% (n = 9).
The “Cape coloured” are the largest population group in
Western Cape and they are historical descendants of cou-
ples of distinct ethnicity. The age at diagnosis for the
coloured patients ranged from 2 to 14 years with a mean
age of 6.6 years; it was 3 to 14 years for the white popula-
tion and 3 to12 years with a mean 5.6 years for the black
children. The mean age of the different ethnic groups was
not statistically significant (p > 0.1).
Gender
There were 40 males and 11 females with an M : F ratio
of 3.6:1 equally represented in all ethnic groups.
Social demographic
Of the all patients, 52.9% lived in an urban setting while
47.1% came from a rural environment. Urban setting was
defined as living in a city and rural as living in a village or
sharing the characteristic of farming or country life. The
rural setting was also correlated with an average income
of less than 400$ per family per month.
Tumour
There was a predominance of abdominal primary tu-
mours (76.4%). A further 3.9% presented with a pelvic
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ing a difference from endemic Burkitt tumours found on
the African Belt. All ethnic groups presented predomin-
antly with abdominal tumours and there was no statistical
significance between the distributions of various sites of
the primary tumours in the groups (p > 0.1).
The majority of patients presented late with the disease
with 58% in Murphy Stage 3 and 23% in Murphy Stage 4.
Lung and bone marrow metastases were most frequent
(29.4% and 25.4% respectively) while 88% of the patients
had abdominal involvement either as a primary site or
with metastases. When comparing ethnicity to the clinical
stage in which patients presented, 90% of the coloured
population and 88% of the black population presented at a
more advanced stage (i.e. 3 or 4) compared to the white
population, where 60% presented in an advanced stage
(p =0.06) (Figure 1).Treatment and survival
The overall five year survival rate was 64.7%. The majority
of patients (90%) were treated with the LMB protocol
1989 and 1996. Only 1 patient died before treatment was
started and 2 received only Vincristine and Prednisone be-
fore demise. A total of 4 patients relapsed (3 in stage 3 of
disease and 1 in stage 4). The sites of relapses were in the
bone marrow (3 cases) and in the lung (1 case).
The stage of the disease at the time of presentation strongly
influenced the outcome with only 41.6% of stage 4 patients
surviving, versus 62% in stage II and 78% in stage III (p =
0.03) (Figure 2). Neutropenic sepsis, mucositis and gastro-
enteritis were the top 3 side effects patients suffered while re-
ceiving therapy (58.8%, 50.9% and 31.3% respectively).
Gender did not have an influence on survival (p > 0.1).
Race did not have an influence of side effect profile or the
relapse rate and for patients who did present with side ef-
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Figure 1 Stage of tumour correlated with ethnic group.Race influenced the outcome of the disease as black chil-
dren presented with more advanced disease than white chil-
dren and the survival between the groups differed markedly.
Viral characteristics
Six out of the 15 patients tested for HIV had a docu-
mented positive result. Only 50% of these patients sur-
vived. The patients with HIV presented with severe illness,
with two out of the six demising before the start of the full
chemotherapy protocol or antiretroviral. They were all
classified as WHO stage 4 HIV disease. The CD4 count
ranged from 304 to 1194 with a mean of 612 and median
of 394. Two patients were on antiretrovirals at the time of
diagnosis and two were started after the diagnosis was
made. All of them had complications.
Discussion
The findings from this study show that children with BL
seen at Tygerberg Hospital (Western Cape, South Africa)
present with clinical features that are more in keeping
with sporadic BL. This differs to what was previously de-
scribed by Hesseling et al. in 1989 which found that the
characteristics of the 22 patients in their study were simi-
lar to African endemic BL [8].In that study 13 of the 22
cases (59%) showed involvement of the jaws which is in
keeping with what is described as endemic BL.
As South Africa is a diverse country with multiple
population groups with different ethnic and cultural
background, the demographics of the patients that were
included in this study reflect largely the greater popula-
tion of the Western Cape (predominantly a coloured
population – 53.9% followed by the black and white
population – 26.7 and 18.4 respectively) [10]. This is
different and unique to the rest of South Africa which
has a predominant black population – 79% [10]. Our
study analyzed possible differences related to BL and
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Figure 2 Stage of tumor versus survival.
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statistical significance in the distribution of sites of the pri-
mary tumours within the various ethnic groups (p > 0.1).
Of note, coloured and black children presented with
more advanced disease than the white children and the
survival ratios between the groups differ markedly.
Coloured and black children with BL presented at a
much younger age (5–6 years) compared to the white
population at 8–9 years.
The younger age presentation is well documented in en-
demic BL, while the older child /younger adolescent pres-
entation is seen more in sporadic BL [11,12]. This study
revealed an age difference between ethnic groups, sugges-
ting that the white population has a tendency to follow the
sporadic pattern.
This cohort displays similar trends in gender distribu-
tion as seen previously.
Male predominance was reported in both types of the
epidemiological variants of BL. Several studies from Israel,
Netherlands, Pakistan and Yemen [13-16] showed that
gender did not have an influence on the prognosis of sur-
vival. Even though males had higher tumour risk both
males and females had similar outcome.
Denis Burkitt first described this tumour in 1958 and
later published epidemiological investigations revealing that
it was found in humid, hot, low lying areas, referring to the
geographic distribution as the “tumour safari”. The tumour
was confined to the African Belt, which extends from east
to west between 10 degrees north and 10 degrees south of
the equator, continuing along the eastern coast of Africa.
The patients in this study all came from the Tygerberg
Hospital’s drainage area (this hospital serves the immediate
surrounding areas, providing primary and secondary health
care to children, as well as tertiary care to all paediatric pa-
tients in the eastern parts of Cape Town and the Northern
and Eastern rural districts of the Western Cape, as well as
to selected cases from Namibia). The patient demographicfor this study showed a negligible difference between the
numbers of patients from rural and urban background
(52.9% and 47.1% respectively). Many patients reside in very
dry, and relatively colder climates where the temperature
drops below 15°C (60°F), showing a marked difference
from the endemic BL climate pattern, where the average
temperature ranges between 18-27°C with a humidity of
30% or higher. The socioeconomic status had no influence
on the incidence of the tumour.
All ethnic groups predominantly presented with abdom-
inal involvement. Jaw (head and neck) tumours are a char-
acteristic feature of BL on the African Belt and are found in
approximately 50% of the cases. These tumours have also
been seen to be age dependent and generally are found in
the younger African child. In our study, ethnicity had no
significant effect on the site of the primary tumour.
Numerous studies have shown the repeated association
between EBV and the c-myc oncogene in the pathogenesis
of eBL [6,10]. On-going studies and current literature
show a link between Plasmodium falciparum and EBV re-
activation as recognised co-factors in the genesis of en-
demic BL [12,13]. There is clear evidence regarding the
role of EBV and malaria in the pathogenesis of endemic
BL and on its association with HIV-1, but insufficient data
to support the role of such factors in sporadic cases, where
EBV is seen in only about 20% of the patients [4].
This area is also not endemic for malaria and there
were no documented malaria cases showing that in this
region Plasmodium falciparum did not play a role in BL
pathogenesis in our study population.
It was clear that when this tumour was complicated by
HIV1 the disease presentation was more severe and the
progression and the outcome were worsened. Of the two
patients who were on ARVs at the time of diagnosis, one
survived and the other demised and a similar outcome was
seen in the two patients who were started on ARVs during
the illness.
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lysed the clinical features, the management and progno-
sis of 2 cohorts of BL: HIV infected children compared to
HIV non-infected children That study showed that, des-
pite a similar distribution by age, sex and stage of disease
between the 2 groups, the mortality ratio was significantly
higher in the HIV positive group [17].
Further investigations and studies are definitely war-
ranted to investigate the effect of ARVs.
The movement away from aggressive surgery and less in-
tensive chemotherapy towards more intensive chemother-
apy and a more conservative surgical approach has been
shown to be a better management strategy with improved
survival outcomes [18] This forms the core of the LMB
protocol that was used in the treatment of the majority of
patients in this study. The more intensive chemotherapy re-
sults in a greater morbidity of the patients with the main
concern being neutropenic sepsis. The high rate of neutro-
penic sepsis seen on this protocol stresses the need for
strict isolation facilities and barrier precautions, which are
often absent or inadequate in resource poor settings. The
complications of the protocol were seen in all stages of the
tumour. Ethnicity also had no influence on the side effect
profile, with previously disadvantaged ethnic groups with
poorer social circumstances having similar morbidity when
compared to ethnic groups with better social circumstance.
The overall survival rate of the patients in this study at
64.7% was comparatively lower than others countries
who have sporadic BL where more than 80% survival
rates are achieved. The major impact on survival came
from the stage of the disease at the time of presentation.
In first world countries cancer-surveillance programs are
more prominent and patients tend to seek medical at-
tention much earlier. The management of the morbidity
of the chemotherapy complications also contributes to
the vast difference in the overall survival rate.
This study illustrates the importance of early cancer
diagnosis of BL in South Africa and the need for increase
awareness and education. Late and advanced presentation
of cancers impacts on treatment, prognosis and ultimately
survival. Just over 80% of patients presented with Murphy
Stage 3 and 4 combined. The previously disadvantaged
ethnic groups of South Africa suffered the brunt of the im-
pact illustrating the lack of education and delay in seeking
early medical advice.
Limitations of the study
The overall limitations of this study include the analysis of a
retrospective data, a small number of patients, missing infor-
mation on viral studies and multiple statistical comparisons.
Conclusion
The clinical presentation of the patients seen at Tygerberg
Hospital, South Africa from 1995 till 2010 was rathersuggestive of sporadic variant of Burkitt Lymphoma with
abdominal tumours most frequently seen.
Advanced disease at presentation associated with HIV
infection contributed to a poorer outcome of the patients.
No difference in outcome was noted between urban and
rural settings. Survival rates remain low compared to the
reported figures from developed countries mainly due to
advanced disease at presentation.
The LMB treatment protocol has a good outcome but
is complicated by significant morbidity. Oncology units
must be equipped with isolation facilities and intensive
infection control procedures must be in place to deal
with the high morbidity seen during the management of
these tumours.
Strong recommendations are warranted for early re-
cognition of childhood cancers as this has a major im-
pact on outcome and survival. Education programmes to
recognise the early signs of cancer are essential and must
take place on all levels from the uneducated rural public
to the medical students and general practitioners.
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